EMA Lapsed: Docetaxel Teva Pharma (docetaxel) — Teva Pharma B.V.

View source ↗

Summary

The EMA lists Docetaxel Teva Pharma as lapsed (withdrawn) for multiple indications including non-small cell lung carcinoma, breast neoplasms, and prostatic neop…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Non-small Cell Lung Cancer
• Prostate Cancer

Drugs mentioned

• Docetaxel Teva Pharma (docetaxel)

Snippet

Status: Lapsed. Therapeutic area: Carcinoma, Non-Small-Cell Lung;Breast Neoplasms;Prostatic Neoplasms. MAH: Teva Pharma B.V.. Decision date: 21/01/2014